A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 47,659 shares of AMRX stock, worth $374,123. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,659
Holding current value
$374,123
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.42 - $8.83 $305,970 - $420,828
47,659 New
47,659 $396,000
Q1 2024

May 15, 2024

BUY
$5.24 - $6.34 $132,687 - $160,541
25,322 New
25,322 $153,000
Q4 2021

Feb 14, 2022

SELL
$3.95 - $5.85 $41,984 - $62,179
-10,629 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$4.31 - $5.64 $44,392 - $58,092
-10,300 Reduced 49.21%
10,629 $57,000
Q2 2021

Aug 16, 2021

BUY
$5.12 - $6.82 $107,156 - $142,735
20,929 New
20,929 $107,000
Q4 2020

Feb 16, 2021

SELL
$3.95 - $5.42 $45,436 - $62,346
-11,503 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$3.54 - $5.27 $2,336 - $3,478
-660 Reduced 5.43%
11,503 $45,000
Q2 2020

Aug 13, 2020

SELL
$2.87 - $5.46 $3,481 - $6,622
-1,213 Reduced 9.07%
12,163 $58,000
Q1 2020

May 15, 2020

SELL
$2.46 - $5.35 $2,710 - $5,895
-1,102 Reduced 7.61%
13,376 $47,000
Q4 2019

Feb 14, 2020

BUY
$2.65 - $5.56 $38,366 - $80,497
14,478 New
14,478 $70,000
Q3 2019

Nov 14, 2019

SELL
$2.29 - $7.1 $70,722 - $219,269
-30,883 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$6.44 - $14.29 $119,983 - $266,236
-18,631 Reduced 37.63%
30,883 $221,000
Q1 2019

May 15, 2019

BUY
$11.87 - $14.84 $587,731 - $734,787
49,514 New
49,514 $702,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.19B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.